Reading CELZ? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CELZ free→Reading CELZ? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CELZ free→QuarterlyIQ Insights · CELZ
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 6, 2025, the Compensation Committee of the Board of Directors of Creative Medical Technology Holdings, Inc. (the “Company”) approved the payment of bonuses to Timothy Warbington, the Company’s Chief Executive Officer, and Donald Dickerson, the Company’s Chief Financial Officer, in the amounts of $100,000 and $25,000, respectively.
Entry into a Material Definitive Agreement. On October 29, 2025, Creative Medical Technology Holdings, Inc. (the “Company”) entered into warrant exercise inducement offer letters (the “Inducement Letters”) with the holders (the “Holders”) of warrants to purchase an aggregate of 1,116,136 shares of the Company’s common stock originally issued on March 6, 2025 (collectively, the “Existing Warrants”), pursuant to which the Holders agreed to exercise the Existing Warrants at their current exercis…
Unregistered Sales of Equity Securities. The disclosure in
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 4, 2025, Creative Medical Technology Holdings, Inc. (the “Company”) adopted a Clawback Policy (the “Policy”) pursuant to Listing Rule 5608(b)(1) of The Nasdaq Stock Market LLC (“Nasdaq”), and filed the Policy with the Securities and Exchange Commission as an exhibit to its Amended Annual Report on Form 10-K. Although the Clawback Policy has been adopted with retroactive effect to Dece…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 10, 2025, the Compensation Committee of the Board of Directors of Creative Medical Technology Holdings, Inc. (the “Company”) approved the payment of bonuses to Timothy Warbington, the Company’s Chief Executive Officer, and Donald Dickerson, the Company’s Chief Financial Officer, in the amounts of $70,000 and $30,000, respectively.
Entry into a Material Definitive Agreement. On March 6, 2025, Creative Medical Technology Holdings, Inc. (the “Company”) entered into warrant exercise inducement offer letters (the “Inducement Letters”) with the holders (the “Holders”) of warrants to purchase an aggregate of 837,104 shares of the Company’s common stock originally issued on October 23, 2024 (collectively, the “Existing Warrants”), pursuant to which the Holders agreed to exercise the Existing Warrants at their current exercise…
Unregistered Sales of Equity Securities. The disclosure in
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.